Jt. Papadakis et al., SODIUM THIOSULFATE IN THE TREATMENT OF TUMORAL CALCIFICATIONS IN A HEMODIALYSIS PATIENT WITHOUT HYPERPARATHYROIDISM, Nephron, 72(2), 1996, pp. 308-312
Extraskeletal tumoral calcifications (TC) may occur in patients with e
nd-stage renal disease. The TC usually develop in the presence of seco
ndary hyperparathyroidism or a high calcium x phosphate product, while
other factors have been also occasionally implicated in their develop
ment. At present, no uniformly accepted effective treatment has been d
escribed for this condition. We describe a 58-year-old female patient
with end-stage renal disease who 7 years after the onset of dialysis p
resented with pain and movement restriction of various joints. A skele
tal X-ray showed huge amounts of periarticular TC. The TC occurred in
the absence of hyperparathyroidism or a high calcium x phosphate produ
ct as evidenced by hormonal and biochemical examination as well as by
a bone biopsy specimen that revealed an adynamic bone disease with sig
nificant aluminum staining. Sodium thiosulfate, an inorganic salt that
has been claimed to inhibit the formation and to favor the solubility
and the mobilization of calcified masses, was administered to the pat
ient, and after a long period of treatment considerable radiological r
egression of the TC with concurrent clinical recovery was noticed. Alu
minum intoxication, along with other factors, was considered to be the
cause of TC development. The use of sodium thiosulfate seemed to be a
reasonable nonspecific therapeutic approach for the management of TC
in this case.